Emily Johnson

Emily Johnson is the Head of Global Intellectual Property Policy, Innovation Law at Bristol Myers Squibb. Emily champions IP policies and strategies that support biopharmaceutical innovation.  She brings specialized experience at the intersection of intellectual property, life sciences, litigation, and public policy.  Prior to joining BMS, Emily represented biopharmaceutical companies in patent litigations and appeals, and she served as the Head of IP Policy & Advocacy at Amgen.  Emily clerked for the Honorable Arthur Gajarsa at the U.S. Court of Appeals for the Federal Circuit.  She currently serves on the Board of Directors of the Intellectual Property Owners Association.